Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-ultrasound.

Urology·2026
Same author

Contactin-1-Associated Membranous Nephropathy after Multiple mRNA 1273 COVID-19 Vaccinations: A Case Report.

Glomerular diseases·2026
Same author

Head-to-head Comparison of Multimodal Imaging for Prostate Cancer Detection and Local Staging with Whole-mount Histopathology Reference.

European urology oncology·2026
Same author

Micro-ultrasound tissue echogenicity predicts prostate cancer grade.

BJUI compass·2026
Same author

AI-enhanced micro-ultrasound improves detection of clinically significant prostate cancer at biopsy.

BJUI compass·2026
Same author

Cross-sectional associations of sleep timing and eating behavior factors with migraine in a predominantly female adult sample.

Chronobiology international·2026
Same journal

Recognition to repair: Managing reservoir complications in inflatable penile prosthesis surgery.

BJUI compass·2026
Same journal

External validation of the preoperative risk evaluation for partial nephrectomy (PREP) score.

BJUI compass·2026
Same journal

Comparison of prostatic urethral lift (PUL) versus water vapour thermal therapy (WVTT): A focus on drug-free status and unplanned admissions.

BJUI compass·2026
Same journal

Chronic idiopathic urinary retention and Fowler's syndrome in women: A multidisciplinary framework for assessment and nonsurgical management.

BJUI compass·2026
Same journal

External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohort.

BJUI compass·2026
Same journal

When disease travels downstream: The effect of intravesical recurrences in patients treated for upper tract urothelial carcinoma.

BJUI compass·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

141

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm.

Alan Priester1,2, Sakina Mohammed Mota1, Kyla P Grunden2

  • 1Avenda Health, Inc. United States.

BJUI Compass
|October 17, 2024
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) cancer mapping accurately predicted extracapsular extension (ECE) in prostate cancer (PCa), outperforming traditional MRI and nomograms. This AI tool shows promise for improving surgical planning and patient outcomes.

Keywords:
MRIartificial intelligenceextracapsular extensionfusion biopsyprostate cancer

More Related Videos

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.4K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

Related Experiment Videos

Last Updated: Jun 10, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

141
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.4K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

Area of Science:

  • Urology
  • Oncology
  • Medical Imaging

Background:

  • Accurate detection of extracapsular extension (ECE) in prostate cancer (PCa) is crucial for treatment planning and predicting outcomes.
  • Current methods including MRI and nomograms have limitations in precisely identifying ECE.
  • AI-driven tools offer potential for enhanced diagnostic accuracy in oncology.

Purpose of the Study:

  • To compare the detection rates of PCa ECE using AI-generated cancer maps versus conventional MRI and nomograms.
  • To evaluate the performance of AI software in predicting ECE risk at both patient and quadrant levels.
  • To assess the potential of AI in improving PCa staging and risk stratification.

Main Methods:

  • Retrospective analysis of 147 patients undergoing MRI-targeted biopsy and radical prostatectomy.
  • Utilized FDA-cleared AI software (Unfold AI) for 3D cancer probability mapping and ECE risk estimation.
  • Compared AI predictions against conventional ECE predictors (MRI Likert scores, capsular contact length, PSMA T stage, Partin tables, and a dedicated nomogram).
  • Evaluated performance using receiver operator characteristic curves and DeLong's test.

Main Results:

  • Unfold AI demonstrated a significantly higher area under the curve (AUC=0.81) for patient-level ECE prediction compared to other methods.
  • At the quadrant level, Unfold AI outperformed MRI Likert scores in posterior (AUC=0.89 vs 0.82) and all quadrants (AUC=0.89 vs 0.82).
  • Unfold AI exhibited improved sensitivity and specificity, with a notably lower false negative rate than MRI, particularly in posterior quadrants.

Conclusions:

  • AI-generated cancer mapping (Unfold AI) accurately predicts ECE risk in PCa, surpassing conventional methods.
  • The AI tool significantly enhances ECE detection over MRI, especially in posterior prostate regions.
  • Improved PCa staging and risk stratification through AI mapping can potentially lead to better oncological and functional outcomes, including informed nerve-sparing surgery.